TDACU

Translational Development Acquisition
$11.55
−$0.46 (−3.83%)Jul 27, 2026

Key metrics

The numbers that frame TDACU today
52wk Low
$10.31
52wk High
$17.29

TDACU stock rating

How TDACU scores on quality, value, growth, momentum and financial health
n/aout of 10
No overall ratingHealthy business, valuation unclear
QualityNo scoren/a/10
GrowthNo scoren/a/10
MomentumGood6.0/10
ValueNo scoren/a/10
Financial HealthNo scoren/a/10

Growth

Revenue and earnings trend for TDACU
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about TDACU
Is Translational Development Acquisition a good buy?
Yes. Translational Development Acquisition has strong momentum.
What is the 52-week high for TDACU stock?
The 52-week high for Translational Development Acquisition is $17.29. The current close of $11.55 is 33.2% below that high.
What is the 52-week low for TDACU stock?
The 52-week low for Translational Development Acquisition is $10.31. The current close of $11.55 is 12% above that low.